Academic Journal of Business & Management, 2020, 2(1); doi: 10.25236/AJBM.2020.020108.
Yu Jiaa and Yuanyuan Zhangb
School of Management, Shanghai University, Shanghai, China
a. [email protected], b. [email protected]
Wise Information Technology of 120 is one of the key measures to promote the reform of medical system. It plays an important role in improving medical efficiency and the allocation of medical resources. Through the analysis of the traditional financial indicators and the new constructed financial indicators of the wise healthcare enterprises and traditional healthcare enterprises, we find that the wise healthcare enterprises are superior to the traditional healthcare enterprises in terms of profitability, operation ability and debt paying ability. At the same time, the research and development ability of the wise healthcare enterprises is obviously higher than that of traditional healthcare enterprises, which also shows that the Wise Information Technology of 120 is the future medical development trends. In addition, by using SPSS software for discriminant analysis, the discriminant model of wise healthcare enterprises and traditional healthcare enterprises is obtained. It is found that the use of "traditional financial indicators + new constructed financial indicators" in discriminant analysis can improve the discriminant accuracy.
Pharmaceutical Industry, Healthcare Enterprises, Financial Indicators
Yu Jia and Yuanyuan Zhang. Differences in Financial Indicators in the Pharmaceutical Industry ——Wise Healthcare Enterprises VS Traditional Healthcare Enterprises. Academic Journal of Business & Management (2020) Vol. 2, Issue 1: 68-76. https://doi.org/10.25236/AJBM.2020.020108.
[1] Wensheng Liu. Wise Information Technology of 120: from concept to application [J]. President of Chinese hospital, 2018 (15): 28-30.
[2] Yawei Cao, Zhipeng Pang. Research on the development trend of Wise Information Technology of 120 [J]. Data communication, 2018 (05): 48-49.
[3] Yuan Fang, Denan Lin. Review of Wise Information Technology of 120 research [J]. New economy, 2014 (19): 70-72.
[4] Su Shen. Research on the current situation and development strategies of Wise Information Technology of 120 construction in China [J]. Shanghai pharmaceutical, 2016, 37 (15): 54-56+60.
[5] Zheng Zeng. Research on the development and trend of Chinese pharmaceutical industry [J]. Economic research reference, 2014 (32): 4-38.
[6] Long Zhang, Dandi Chen, DiChen, Jun Liu. Financial status analysis of China's biomedical industry based on dupont analysis [J]. China Pharmacy, 2014, 25 (21): 1924-1927.